FIRA Nord-Est 2
Overview
FIRA Nord-Est 2 is a generalist seed fund that invests in innovative companies in the Digital, Health, Bioeconomy, Energy Transition, and Industry of the Future sectors located in the Hauts-de-France, Grand Est, and Bourgogne-Franche-Comté regions of France.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Hemerion Therapeutics | May 2025 | Series A | Co-investor |
| Osiris Agriculture | Nov 2023 | Seed | Lead |
| Japet Medical | Oct 2017 | Seed | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is FIRA Nord-Est 2 based?
FIRA Nord-Est 2 is headquartered in France.
When was FIRA Nord-Est 2 founded?
FIRA Nord-Est 2 was founded in 2021.
How many portfolio companies does FIRA Nord-Est 2 have?
FIRA Nord-Est 2 has 3 portfolio companies in Caplight's dataset.
What are some companies in FIRA Nord-Est 2's portfolio?
Portfolio companies visible on Caplight include Hemerion Therapeutics, Osiris Agriculture, Japet Medical.
What was FIRA Nord-Est 2's most recent investment shown here?
FIRA Nord-Est 2's most recent investment in this portfolio sample was in Hemerion Therapeutics in 2025.
What sectors does FIRA Nord-Est 2 focus on?
FIRA Nord-Est 2 focuses on Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, Frontier & Industrial Tech, Energy & Sustainability.
What company stages does FIRA Nord-Est 2 focus on?
FIRA Nord-Est 2 typically invests at the Early stage.
What is FIRA Nord-Est 2's AUM?
FIRA Nord-Est 2's assets under management are estimated between $99.4M and $99.4M.